{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:16:41Z","timestamp":1759961801396},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,8,26]],"date-time":"2015-08-26T00:00:00Z","timestamp":1440547200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11655-015-2151-0","type":"journal-article","created":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T18:20:22Z","timestamp":1440526822000},"page":"918-924","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Therapeutic and immunoregulatory effect of GATA-binding protein-3\/T-box expressed in T-cells ratio of astragalus polysaccharides on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats"],"prefix":"10.1007","volume":"22","author":[{"given":"Yong-jian","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-ming","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-yuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,26]]},"reference":[{"key":"2151_CR1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-3083.2000.00658.x","volume":"51","author":"TT MacDonald","year":"2000","unstructured":"MacDonald TT, Monteleone G, Pender SL. Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol 2000;51:2\u20139.","journal-title":"Scand J Immunol"},{"key":"2151_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1874467210801030195","volume":"1","author":"P Dharmani","year":"2008","unstructured":"Dharmani P, Chadee K. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key. Curr Mol Pharmacol 2008;1:195\u2013212.","journal-title":"Curr Mol Pharmacol"},{"key":"2151_CR3","first-page":"87","volume":"3","author":"SL Peng","year":"2006","unstructured":"Peng SL. The T-box transcription factor T-bet in immunity and autoimmunity. Cell Mol Immunol 2006;3:87\u201395.","journal-title":"Cell Mol Immunol"},{"key":"2151_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.cr.7310002","volume":"16","author":"J Zhu","year":"2006","unstructured":"Zhu J, Yamane H, Cote-Sierra J, Guo L, Paul WE. GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specifi c factors. Cell Res 2006;16:3\u201310.","journal-title":"Cell Res"},{"key":"2151_CR5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11655-006-0262-y","volume":"12","author":"G Wang","year":"2006","unstructured":"Wang G, Liu CT, Wang ZL, Yan CL, Luo FM, Wang L, et al. Effects of Astragalus membranaceus in promoting T-helper cell type 1 polarization and interferon-gamma production by up-regulating T-bet expression in patients with asthma. Chin J Integr Med 2006;12:262\u2013267.","journal-title":"Chin J Integr Med"},{"key":"2151_CR6","first-page":"680","volume":"6","author":"W Zhang","year":"2006","unstructured":"Zhang W, Zhao F. Effect of supplementary therapy with astragalus on serum Th1\/Th2 in children with allergic rhinitis. Chin Remed Clin (Chin) 2006;6:680\u2013683.","journal-title":"Chin Remed Clin (Chin)"},{"key":"2151_CR7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.intimp.2006.08.016","volume":"7","author":"S Li","year":"2007","unstructured":"Li S, Zhang Y, Zhao J. Preparation and suppressive effect of astragalus polysaccharide in glomerulonephritis rats. Int Immunopharmacol 2007;7:23\u201328.","journal-title":"Int Immunopharmacol"},{"key":"2151_CR8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3736\/jcim20080212","volume":"6","author":"R Li","year":"2008","unstructured":"Li R, Qiu S, Chen H. Immunomodulatory effects of astragalus polysaccharides on the type 1 diabetic mice. J Chin Integr Med (Chin) 2008;6:166\u2013170.","journal-title":"J Chin Integr Med (Chin)"},{"key":"2151_CR9","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.3748\/wjg.v11.i37.5787","volume":"11","author":"JK Ko","year":"2005","unstructured":"Ko JK, Lam FY, Cheung AP. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol 2005;11:5787\u20135794.","journal-title":"World J Gastroenterol"},{"key":"2151_CR10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cyto.2009.05.014","volume":"47","author":"JK Ko","year":"2009","unstructured":"Ko JK, Chik CW. The protective action of Radix astragalus membranaceus against hapten-induced colitis through modulation of cytokines. Cytokine 2009;47:85\u201390.","journal-title":"Cytokine"},{"key":"2151_CR11","first-page":"260","volume":"18","author":"YJ Gao","year":"2010","unstructured":"Gao YJ, Zhu F, Qian JM. Effects of astragalus polysaccharides on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats. Chin J Clin Nutr (Chin) 2010;18:260\u2013264.","journal-title":"Chin J Clin Nutr (Chin)"},{"key":"2151_CR12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0016-5085(89)80079-4","volume":"96","author":"GP Morris","year":"1989","unstructured":"Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic infl ammation and ulceration in the rat colon. Gastroenterology 1989;96:795\u2013803.","journal-title":"Gastroenterology"},{"key":"2151_CR13","first-page":"238","volume":"69","author":"HS Cooper","year":"1993","unstructured":"Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238\u2013249.","journal-title":"Lab Invest"},{"key":"2151_CR14","first-page":"G527","volume":"258","author":"JL Wallace","year":"1990","unstructured":"Wallace JL, Keenan CM. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am J Physiol 1990;258:G527\u2013G534.","journal-title":"Am J Physiol"},{"key":"2151_CR15","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1046\/j.1365-2036.1999.00633.x","volume":"13","author":"AP Sykes","year":"1999","unstructured":"Sykes AP, Bhogal R, Brampton C, Chander C, Whelan C, Parsons ME, et al. The effect of an inhibitor of matrix metalloproteinases on colonic inflammation in a trinitrobenzenesulphonic acid rat model of inflammatory bowel disease. Aliment Pharmacol Ther 1999;13:1535\u20131542.","journal-title":"Aliment Pharmacol Ther"},{"key":"2151_CR16","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/0016-5085(84)90202-6","volume":"87","author":"JE Krawisz","year":"1984","unstructured":"Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344\u20131350.","journal-title":"Gastroenterology"},{"key":"2151_CR17","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.3748\/wjg.v12.i29.4628","volume":"12","author":"K Nakamura","year":"2006","unstructured":"Nakamura K, Honda K, Mizutani T, Akiho H, Harada N. Novel strategies for the treatment of inflammatory bowel disease: selective inhibition of cytokines and adhesion molecules. World J Gastroenterol 2006;12:4628\u20134635.","journal-title":"World J Gastroenterol"},{"key":"2151_CR18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.coph.2009.07.005","volume":"9","author":"MJ Waldner","year":"2009","unstructured":"Waldner MJ, Neurath MF. Novel cytokine-targeted therapies and intestinal infl ammation. Curr Opin Pharmacol 2009;9:702\u2013707.","journal-title":"Curr Opin Pharmacol"},{"key":"2151_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.MIB.0000194183.92671.b6","volume":"12","author":"IJ Fuss","year":"2006","unstructured":"Fuss IJ, Becker C, Yang Z, Groden C, Hornung RL, Heller F, et al. Both IL-12p70 and IL-23 are synthesized during active crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm Bowel Dis 2006;12:9\u201315.","journal-title":"Inflamm Bowel Dis"},{"key":"2151_CR20","first-page":"3749","volume":"27","author":"K Mitsuyama","year":"2007","unstructured":"Mitsuyama K, Matsumoto S, Masuda J, Yamasakii H, Kuwaki K, Takedatsu H, et al. Therapeutic strategies for targeting the IL-6\/STAT3 cytokine signaling pathway in infl ammatory bowel disease. Anticancer Res 2007;27:3749\u20133756.","journal-title":"Anticancer Res"},{"key":"2151_CR21","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1096\/fj.08-121236","volume":"23","author":"AC Liberman","year":"2009","unstructured":"Liberman AC, Druker J, Refojo D, Holsboer F, Arzt E. Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells. FASEB J 2009;23:1558\u20131571.","journal-title":"FASEB J"},{"key":"2151_CR22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm0602-567","volume":"8","author":"MF Neurath","year":"2002","unstructured":"Neurath MF, Finotto S, Glimcher LH. The role of Th1\/Th2 polarization in mucosal immunity. Nat Med 2002;8:567\u2013573.","journal-title":"Nat Med"},{"key":"2151_CR23","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1365-2222.2008.03067.x","volume":"38","author":"H Bowen","year":"2008","unstructured":"Bowen H, Kelly A, Lee T, Lavender P. Control of cytokine gene transcription in Th1 and Th2 cells. Clin Exp Allergy 2008;38:1422\u20131431.","journal-title":"Clin Exp Allergy"},{"key":"2151_CR24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1023\/A:1023381027062","volume":"23","author":"D Agnello","year":"2003","unstructured":"Agnello D, Lankford CS, Bream J, Morinobu A, Gadina M, O'Shea JJ, et al. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol 2003;23:147\u2013161.","journal-title":"J Clin Immunol"},{"key":"2151_CR25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-1759(03)00200-X","volume":"278","author":"H Chakir","year":"2003","unstructured":"Chakir H, Wang H, Lefebvre DE, Webb J, Scott FW. T-bet\/ GATA-3 ratio as a measure of the Th1\/Th2 cytokine profi le in mixed cell populations: predominant role of GATA-3. J Immunol Methods 2003;278:157\u2013169.","journal-title":"J Immunol Methods"},{"key":"2151_CR26","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/00029330-200608020-00013","volume":"119","author":"L Dong","year":"2006","unstructured":"Dong L, Chen M, Zhang Q, Li LZ, Xu XQ, Xiao W. T-bet\/ GATA-3 ratio is a surrogate measure of Th1\/Th2 cytokine profi les and may be novel targets for CpG ODN treatment in asthma patients. Chin Med J (Engl) 2006;119:1396\u20131399.","journal-title":"Chin Med J (Engl)"},{"key":"2151_CR27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1517\/14728222.6.6.619","volume":"6","author":"B Weigmann","year":"2002","unstructured":"Weigmann B, Neurath MF. T-bet as a possible therapeutic target in autoimmune disease. Expert Opin Ther Targets 2002;6:619\u2013622.","journal-title":"Expert Opin Ther Targets"},{"key":"2151_CR28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2174\/156801005774322153","volume":"4","author":"A Doganci","year":"2005","unstructured":"Doganci A, Neurath MF, Finotto S. Mucosal immunoregulation: transcription factors as possible therapeutic targets. Curr Drug Targets Infl amm Allergy 2005;4:565\u2013575.","journal-title":"Curr Drug Targets Infl amm Allergy"},{"key":"2151_CR29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1057","volume":"3","author":"AM Mowat","year":"2003","unstructured":"Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003;3:331\u2013341.","journal-title":"Nat Rev Immunol"},{"key":"2151_CR30","doi-asserted-by":"crossref","first-page":"S723","DOI":"10.1097\/00005176-200406003-00003","volume":"39","author":"AM Mowat","year":"2004","unstructured":"Mowat AM, Millington OR, Chirdo FG. Anatomical and cellular basis of immunity and tolerance in the intestine. J Pediatr Gastroenterol Nutr 2004;39 Suppl 3:S723\u2013S724.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2151_CR31","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1084\/jem.182.5.1281","volume":"182","author":"MF Neurath","year":"1995","unstructured":"Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995;182:1281\u20131290.","journal-title":"J Exp Med"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-015-2151-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11655-015-2151-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-015-2151-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-015-2151-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T20:41:14Z","timestamp":1567111274000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11655-015-2151-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,26]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2151"],"URL":"https:\/\/doi.org\/10.1007\/s11655-015-2151-0","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,26]]}}}